Rating History for Acceleron Pharma (XLRN) by Wolfe Research
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/19/2021 | Andrew Galler | New Coverage | Outperform (N/A) |
183.00 (N/A) |
117.26 (178.75) |
52.44% | Details |
 |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/19/2021 | Andrew Galler | New Coverage | Outperform (N/A) |
183.00 (N/A) |
117.26 (178.75) |
52.44% | Details |
|
|||||||
